Global #CBD/#Hemp Industry Snapshot (OTC: $CSUI) (OTC: $MJNA) (CSE: $TGIF.C) (OTCQX: $TGIFF), (TSXV: $KHRN.V) (OTCQX: $KHRNF); @SuisseCorp @1933Industries @MJNA_INC @KhironLife
How Distribution
Platforms Are Growing the Sector
Point
Roberts WA, Delta, BC –September 22, 2020 - Investorideas.com, a
leading investor news resource covering hemp and cannabis stocks releases a
special report on the continued growth of the global CBD/hemp industry as additional
international markets come into play and how smart companies hedging for the
future are putting their focus into globalized distribution systems.
Read this article,
featuring CSUI in full at https://www.investorideas.com/news/2020/cannabis/09221CSUI-MJNA-TGIF-KHRN.asp
As
we see more global acceptance of the hemp/CBD industry, whether in the form of
new import/export regulations coming into play in South America, potential
markets opening up South East Asia, Japan and South Korea or larger companies
like Amazon being more acceptant of hemp/CBD products, the CBD industry is
going global faster than many anticipated, especially in the midst of a global
pandemic. That being said, one of the most significant drivers of this industry
today is the renewed focus on health and wellness and immune boosting products that
we’ve seen ramp up due to the COVID-19 pandemic.
One company based out of Switzerland, Cannabis Suisse Corp. (OTC: CSUI), a fully-licensed Swiss cannabis cultivation and distribution company for recreational tobacco products and medical CBD oils, recently announced its own online expansion plans including the upcoming launch of a new brand on Amazon.
Сannabis Suisse Corp. is
developing its own line of products including hemp oil, hemp protein, hemp
gummies and hemp hearts with all the appropriate certificates and licenses, for
sale on Amazon.
This news follows a recent
announcement for online distribution of its cannabis
and CBD products with uWeed from their retail outlets and online store
(www.uweed.ch).
The expansion into
online sales of hemp gives the company, which is headquartered in Switzerland,
wider access and inroads into US markets as the legal environment for CBD
products evolves.
Mr.
Alain Parrik, COO & Director said, “Amazon is an important distribution
outlet for us as we ramp up for expansion across multiple online retail
platforms. Introducing a new line of hemp products paves the wave for
additional products in the future.”
Cannabis
Suisse Corp. will be in compliance with Amazon rules and respects their
position that CBD is currently banned on Amazon but hemp products are not.
The Company, as a registered
manufacturer of both products will continue to use flowers with the highest
concentration of CBD. For the new Amazon product line, oil will be squeezed
from the seeds allowing Cannabis Suisse to use the whole plant in its
production and benefit from it.
The Company grows high quality,
organic cannabis with sustainable, all-natural principles. Cannabis Suisse
products are laboratory tested to ensure the end users have access to a
standardized, safe and consistent product.
Source: Brightfield
Group Quarterly CBD Consumer Survey, Q2, 2020, Sample size = 5,000
Looking
more to domestic markets, 1933
Industries Inc. (CSE:
TGIF) (OTCQX:
TGIFF), a vertically-integrated cannabis consumer packaged
goods company with a diverse portfolio of consumer-driven brands, recently announced that it
has set up distribution of its Canna Hemp™ line of wellness products in
conjunction with CBD Plus, the largest and most trusted supplier of CBD
products across the United States.
The
Company reports that its wholly-owned subsidiary, Infused MFG, signed a Master
Services and Supply Agreement with MCV Enterprises LLC, an Oklahoma company
doing business as CBD Plus and CBD Plus USA, for the marketing and sale of
Canna Hemp™ products in CBD Plus corporate-owned and franchisee brick and
mortar retail stores. The one-year Agreement includes a 45-day trial period,
effective immediately.
CBD Plus
is focused in the Midwest and Southern US, with over 120 locations and growing -
in Texas, Oklahoma, Kansas, Arkansas, Tennessee, Georgia, Florida, North
Carolina, and Maryland. The partnership with CBD Plus is another important step
for the Company as it builds the Canna Hemp™ line as a leading brand in the US
CBD market. According to the latest outlook by the Brightfield Group,
hemp-based CBD US sales will reach $12.4 billion by 2023 and $16.8 billion by
2025.
Mr.
Eugene Ruiz, President of 1933 Industries said, "CBD Plus is a
well-respected source of safe, legal and affordable CBD products that meet the
highest standards in the industry. We are pleased that our Canna Hemp™ line
meets and exceeds those high standards. We look forward to collaborating with
CBD Plus to increase awareness and education regarding the benefits and value
of CBD in our everyday lives."
"CBD
Plus and its family of franchisees is proud to announce its relationship with
1933 industries", said Mr. Charles V. Reynolds III, CEO of CBD Plus.
"We look forward to introducing Canna Hemp™ products to our entire
customer base nationwide. Quality Assurance and Cannabis Education have always
been cornerstones of the CBD Plus USA mission, and we are excited to partner
with a brand such as Canna Hemp™ that shares those values. We remain committed
to helping educate the public on all of the benefits and uses of quality CBD,
and we believe this relationship aligns with our goals."
CBD Plus
has been committed to improving the lives of communities since 2017, and has
now grown into a trusted source of CBD products in the US. Founded on the
cornerstone of empowering customers to live their best lives, CBD Plus has
become an authoritative advocate for CBD, and a dedicated educator of the
benefits of CBD oil. CBD Plus offers a variety of self-care and lifestyle
products with CBD that exceeds the industry standard of quality, producing
carefully extracted, pesticide-free, and non-GMO products.
Looking
back to the international market, Medical
Marijuana, Inc. (OTC:
MJNA), the first-ever publicly traded cannabis company in
the United States that launched the world’s first-ever cannabis-derived
nutraceutical products, brands and supply chain, recently
announced that its subsidiary HempMeds® Brasil had its best
revenue month ever in Company history in August 2020.
“Since
2015, HempMeds® Brasil has sold more than 80,000 units of cannabidiol (CBD) to
Brazilian citizens,” said Medical Marijuana, Inc. CEO, Dr. Stuart Titus. “We
are proud to be the recipients of the first permits to import CBD into Brazil
and we have been able to become industry leaders there.”
“Our
Company was formed and is led by Brazilians – we care immensely about providing
people here with affordable, high-quality CBD products that are legal and
scientifically-proven,” said HempMeds® Co-CEO, Caroline Heinz. “We have
showcased to citizens even despite a global pandemic and a very poor currency
exchange rate, we have been able to increase our sales and make our products
affordable for the struggling economy through adjusting our prices and offering
payment plans.”
Before
becoming Co-CEO of HempMeds®’ operations, Heinz served as Vice President of
HempMeds® Brasil. She joined the Company in 2014 and helped pass legislation to
get the Brazilian government to subsidize CBD for several indications. She was
also able to establish two HempMeds® Brasil offices and create a network of
Brazilian doctors and medical professionals.
Khiron Life Sciences Corp. (TSXV:
KHRN) (OTCQX:
KHRNF), a vertically integrated cannabis leader with core
operations in Latin America and Europe, recently
announced that it has entered into an exclusive distribution
agreement with Rappi SAS, the leading Latin American last-mile multi-vertical
platform that is backed with a USD 1 billion investment from Softbank Group
Corp., and Softbank Vision Fund. The
expansive agreement comprises a 6-month exclusive distribution partnership
between Rappi and Khiron to introduce and distribute the Company's CPG product
portfolio across Latin America through the Rappi platform, starting with
KuidaTM, the Company's branded CBD skincare product line, with the potential to
build on the partnership over time.
Beyond a
standard vendor agreement, this expanded partnership introduces the Company's
CBD-based Wellbeing products to millions of Rappi users across Latin America
through its sophisticated technology and advanced customer-centric marketing
strategies. With the Kuida store already launched on Rappi in May 2020 for the
Colombian market, distribution will be expanded to Uruguay and Costa Rica,
where Kuida has been recently approved. The Company also intends to introduce
its product line through Rappi's fast growing consumer base to countries such
as Brazil, Mexico, Ecuador and Chile, subject to regulatory approvals.
Colombia's
Rappi is the market leading multi-vertical application in Latin America with a
presence in Brazil, Colombia, Mexico, Argentina, Chile, Ecuador, Costa Rica,
Uruguay and Peru.
Through
its platform, customers buy products and services and receive home delivery
across multiple categories, including, medical, health, grocery, restaurants,
pharmacies, beverage and professional services among others. In addition, the
application has a virtual wallet, RappiPayTM, where users can make P2P
transfers and payments. Rappi has an
average of more than 10 million active users monthly, according to research
firm Apptopia, providing deliveries for almost 100,000 businesses in LatAm,
including over 13 million deliveries in Colombia alone.
"Rappi
is the delivery brand that everyone in Latin America knows and uses daily. The partnership
with Rappi reduces our product launch and logistics costs and transforms our
availability and exposure to millions of customers across the region. Rappi is
the last-mile delivery brand that will help us bring Khiron product to more
customers than ever before. We are proud to establish this first-of-its-kind
partnership between these two companies, which are both industry leaders in
LatAm, and were both founded by Colombians," comments Alvaro Torres,
Khiron CEO and director.
"As
the market for consumer cannabis products and services globalizes it is a
natural fit for us to partner with Khiron to meet our app users´ needs. Like
us, they are a recognized leader in the region, and an innovator in bringing
quality products to market, "comments Simon Borrero, Rappi SAS CEO.
As the
CBD/hemp space continues to gain global momentum, new distribution platforms
and models as well as a heavy focus on product quality, consistency and
efficacy will become more and more paramount for companies looking to be a global
player and make no mistake, this is a global play. With companies like Amazon
now also entering into the space, the level of competition has risen
dramatically and investors should now be looking at the distribution and supply
chain of any CBD/hemp company first and foremost as this looks to be an
impactful factor moving forward.
About
Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third
party news, research and original financial content. Learn about investing in
stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining,
sports biotech, water, renewable energy and more. Investor Idea’s original
branded content includes the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move
podcast and column, Cleantech
and Climate Change , Exploring
Mining
the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investing involves risk and possible losses. This
site is currently compensated for news publication and distribution, social
media and marketing, content creation and more. Disclosure is posted for each
compensated news release, content published /created if required but otherwise
the news was not compensated for and was published for the sole interest of our
readers and followers. Contact management and IR of each company directly
regarding specific questions. Disclosure: this news article featuring
CSUI is a paid for news release on Investorideas.com – third party (two
thousand) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each country. Please
read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Follow
us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile
App
for iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact
Investorideas.com
800-665-0411
Get
more Cannabis Stock Investor Ideas - news,
articles, podcasts and stock
directories
Buy a cannabis guest post on Investorideas.com
No comments:
Post a Comment